Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adacel Polio
- Development stage
- Approved
- Lead developer
- Sanofi
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
**Adacel Polio** is a combination vaccine providing active immunization against tetanus, reduced diphtheria, acellular pertussis (whooping cough), and inactivated poliovirus types 1, 2, and 3 (Vero cell-derived). It contains tetanus toxoid, diphtheria toxoid, pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), fimbriae types 2 and 3 (FIM), and inactivated poliovirus antigens adsorbed on aluminum phosphate. Developed and manufactured by Sanofi, it is administered as a sterile suspension for intramuscular injection in a 0.5 mL dose, primarily used as a booster in children, adolescents, and adults to maintain immunity against these diseases.[1][3][9]
- Brand names
- Adacel Polio
- Other names
- Tdap-IPVdTaP-IPVDiphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)
02
Targets
TCR (T cell antigen receptor complex)
Beyond the preview
Go deeper on Adacel Polio.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adacel Polio.